The collagen type 1 NEOSILK®, developed in an innovative procedure, isolated from the silk cocoon of the silkworm, distinguishes itself by its high purity and, above all, the convincing homogeneity with human collagen. The Frankfurt-based PolyNeo GmbH as the exclusive distribution partner with NEOSILK® provides an essential base for versatile products in cosmetics and aesthetic medicine. Users profit by the positive qualities of the active agent. Thanks to its excellent biocompatibility NEOSILK® is optimally suitable to be used in skincare products fighting the natural skin aging process or supporting the regeneration of damaged skin. Collagen is an important component of the cellular structure of skin tissue. The natural decrease of collagen production results in the well-known and feared skin aging and reduces skin’s regeneration ability. With NEOSILK® PolyNeo offers a straightforward possibility to compensate for the collagen deficiency and to promote skin’s own healing powers by targeted collagen use.

NEOSILK® already has proven its suitability in numerous products of international cosmetics manufacturers. Meanwhile, NEOSILK® is used in all common product types, such as cleansing gels, lotions, creams, masks, or eye serums, and lip balms. In a strategic cooperation with the Italian developer and manufacturer of customer-specific medical products, 303 Pharma S.R.L., PolyNeo successfully and specifically has further developed the application of NEOSILK® collagen in the segment of aesthetic and regenerative medicine.  

As a result of several years of intensive work, 303 Pharma on the base of NEOSILK® presents a wound healing gel of class III medical devices in the form of a spray, and a R-mousse of class I medical devices to soothe and regenerate the skin after cosmetic treatments. In addition to these products for external use, 303 Pharma also uses NEOSILK® in a regenerating collagen-based injection solution. The class III medical device is available in 2 ml syringes to be used for skin injections. As food supplement, NEOSILK® collagen, among others, has a positive effect on cellular formation processes in the skin and can help to alleviate the development of joint problems due to wear.

NEOSILK® is also used in products for the protection and regeneration of the oral mucous membrane and the eye tissue in veterinarian medicine. For example, new products of 303 Pharma are used for dogs and cats and, in the segment, too, profits by the proven positive qualities of NEOSILK® collagen.

303 Pharma not only has established the further development and application of NEOSILK® in new, innovative medical devices but also has provided evidence of its positive effects in many studies.

„We are convinced that the targeted further development of NEOSILK® in close cooperation with 303 Pharma will open several other fields of application”, Eduard Albrecht, managing director of PolyNeo GmbH, explains. „We look forward to intensifying our future cooperation and assisting our customers in the industry with new formulations and adequate concepts with our joined forces.”

Über die PolyNeo GmbH

PolyNeo GmbH is an international commercial company for the cosmetics market with headquarters in Frankfurt am Main. Its main focus is on innovative, effective and sustainable raw materials. The guiding principle is to detect the newest and most efficient developments and make them available to cosmetics.

According to the motto "ideas come true", PolyNeo sees itself as the partner for its customers assisting them in the development and market launch of the finished products resulting from the raw materials.

The founders bring in 26 years of experience in the international business. In the course of the further development of the company, in 2018, the focus has been shifted to the cosmetics market and the product portfolio has been expanded continually in this segment.

Firmenkontakt und Herausgeber der Meldung:

PolyNeo GmbH
Borsigallee 12
60388 Frankfurt am Main
Telefon: +49 (699) 4207245
http://www.polyneo.eu

Ansprechpartner:
Dr. Serk Naymann
Senior Business Development Manager
Telefon: +49 (0)69 94 20 72-21
E-Mail: s.naymann@polyneo.eu
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel